Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase I trial is studying the side effects and best dose of arsenic trioxide and
radiation therapy in treating patients with newly diagnosed malignant glioma. Drugs such as
arsenic trioxide may stop the growth of malignant glioma by stopping blood flow to the tumor.
Radiation therapy uses high-energy x-rays to damage tumor cells. Combining arsenic trioxide
with radiation therapy may kill more tumor cells.